查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1552594

胞外體市場規模、佔有率、趨勢分析報告：按產品/服務、按工作流程、按應用、按最終用途、按地區、細分市場預測，2024-2030

Exosomes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Instruments), By Workflow (Isolation Methods, Downstream Analysis), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

胞外體市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球胞外體市場規模將達到7.942億美元，預測期內複合年成長率為28.38%。

推動市場的關鍵因素包括胞外體分離和分析程序的技術進步、政府和非政府胞外體研究政府措施的成長以及癌症盛行率的增加。例如，根據世界衛生組織 (WHO) 統計，2020 年約有 1,000 萬人死於癌症，癌症成為全球主要死亡原因之一。由於識別癌症生物標記、檢測感染因子以及發現神經退化疾病和心血管疾病 (CVD) 治療方案的需求不斷增加等因素，該行業預計將快速成長。

與健康個體相比，患有各種疾病的患者從細胞釋放到體液中的胞外體現出不同的RNA、蛋白質和脂質含量。因此，胞外體可用於開發使用生物標記識別的診斷程序。因此，對快速、準確和微創診斷程序的需求不斷成長，有望成為胞外體應用的成長機會。 COVID-19 大流行導致 2020 年調查胞外體診斷和治療潛力的臨床試驗暫停。此外，國家封鎖法規、供應鏈中斷以及對 COVID-19 相關產品的投資轉移減少了與胞外體相關的研發活動。

儘管 2020 年帶來了負面影響，但這場大流行預計將為基於胞外體的 COVID-19 疫苗和治療方法的開發開闢新的前景，從而推動未來幾年的行業成長。例如，2021 年 3 月，美國生物技術研究機構 Cell Guidance Systems 宣布計劃開發胞外體療法來治療 COVID-19 疾病。此外，政府和非政府胞外體研究政府措施的成長可能會推動研究期間的成長。例如，2023年1月，Mantra Bio籌集了900萬美元資金，用於推進具有先導目標的胞外體治療計畫的開發。

同樣，2021 年 2 月，Evox Therapeutics 籌集了 9,518 萬美元資金，用於推進胞外體療法並在全球擴展其領先的EXOME平台 DeliverEX。然而，有關胞外體產品核准和商業化的嚴格法規可能會阻礙預測期內的產業成長。此外，將胞外體引入各種應用相關的技術困難可能會阻礙它們在研究期間的生長。主要挑戰包括缺乏有效的轉染策略以及需要最佳化精製方法。預計此類挑戰將阻礙市場成長。

胞外體市場報告亮點

  • 2023 年，套件和試劑部門佔據了最大的收益佔有率。細胞外囊泡的分離是一個困難、特異性且費力的過程。因此，主要企業正在推出創新的套件和試劑來擴大胞外體的應用，從而推動該領域的成長。
  • 按工作流程分類，下游分析領域在 2023 年佔據最大佔有率。主要企業正在提供各種技術先進的產品，以增強下游分析的效用，這可能會對細分市場的成長產生正面影響。
  • 由於胞外體在癌症診斷、預後和治療中的廣泛應用，2023年癌症應用領域佔據市場主導地位。
  • 由於研發活動增加，2023 年製藥和生技公司的最終用途將引領業界。
  • 由於主要參與者的存在、用於檢測新生物標記的政府資金增加以及慢性病的高發病率，北美將成為 2023 年的主導地區。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章胞外體市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場前景
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 胞外體市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19 影響分析

第 4 章胞外體市場：按產品/服務分類的估計和趨勢分析

  • 細分儀表板
  • 按產品/服務分類的全球胞外體市場波動分析
  • 2018-2030 年全球胞外體市場規模與趨勢分析（依產品/服務）
  • 試劑套件和試劑
  • 裝置
  • 服務

第5章胞外體市場：依工作流程進行估算與趨勢分析

  • 細分儀表板
  • 依工作流程分析全球胞外體市場波動
  • 2018-2030 年全球胞外體市場規模與趨勢分析（依工作流程）
  • 隔離方法
  • 下游分析

第6章胞外體市場：按應用估算與趨勢分析

  • 細分儀表板
  • 全球胞外體市場應用變遷分析
  • 2018-2030 年全球胞外體市場規模與趨勢分析（按應用）
  • 癌症
  • 神經退化性疾病
  • 心血管疾病
  • 感染疾病
  • 其他

第7章胞外體市場：依最終用途分類的估計與趨勢分析

  • 細分儀表板
  • 全球胞外體市場的最終用途變化分析
  • 2018-2030 年全球胞外體市場規模與趨勢分析（依最終用途）
  • 製藥和生物技術公司
  • 醫院和診斷中心
  • 學術研究所

第8章胞外體市場：區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 2018-2030年北美市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018年至2030年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 2018-2030 年亞太市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
    • 新加坡
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018年至2030年中東和非洲市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/名單
    • Bio-Techne
    • Danaher
    • Hologic Inc.
    • Fujifilm Holdings Corporation
    • Lonza
    • Miltenyi Biotec
    • Qiagen
    • Thermo Fisher Scientific, Inc.
    • Abcam Plc
    • RoosterBio, Inc.
Product Code: GVR-2-68038-298-3

Exosomes Market Growth & Trends:

The global exosomes market size is projected to reach USD 794.2 million by 2030, registering a CAGR of 28.38% over the forecast period, according to a new report by Grand View Research, Inc. The major factors driving the market include technological advancements in exosome isolation and analytical procedures, growth in government and non-government initiatives for exosome research, and the increasing prevalence of cancer. For instance, according to the World Health Organization (WHO), in 2020 there were about 10 million deaths due to cancer, making it one of the foremost causes of death worldwide. The industry is anticipated to witness rapid growth, owing to the factors, such as the growing need for the identification of cancer biomarkers, detection of infectious agents, and discovery of treatment options for neurodegenerative & Cardiovascular Diseases (CVDs).

Exosomes released by cells into body fluids display different RNA, protein, and lipid contents in patients with various disease conditions as compared to healthy individuals. Hence, exosomes can be used for the development of diagnostic procedures using biomarker identification. The rising demand for fast, accurate, and minimally invasive diagnostic procedures, thus, represents a promising opportunity for the growth of exosome applications. The COVID-19 pandemic led to the disruption of clinical trials investigating the diagnostic and therapeutic potential of exosomes in 2020. In addition, nationwide lockdown restrictions, disruption of supply chains, and diversion of investments toward COVID-19-related products led to a decrease in the research and development activities involving exosomes.

Despite the adverse impact in 2020, the pandemic has opened up several new prospects for the development of COVID-19 vaccines and treatments with the use of exosomes, which, in turn, is expected to boost industry growth over the coming years. For instance, in March 2021, Cell Guidance Systems, a U.S.-based biotechnology research organization, announced plans for the development of exosome therapeutics for treating COVID-19 disease. Moreover, growth in government and non-government initiatives for exosome research is likely to drive the growth during the study period. For instance, in Jan 2023, Mantra Bio raised funding of USD 9 million to advance the development of its lead-targeted exosome therapeutics program.

Similarly, in February 2021, Evox Therapeutics raised a funding of USD 95.18 million to advance the exosome therapeutics and expand the company's leading exome platform DeliverEX globally. However, stringent regulations pertaining to the approval and commercialization of exosome products may hamper the growth of the industry over the forecast period. In addition, technical difficulties associated with the implementation of exosomes in various applications may hamper the growth during the study period. Some of the major challenges include the lack of efficient transfection strategies and the need for optimization of purification methods. Such, challenges are anticipated to impede the market growth.

Exosomes Market Report Highlights:

  • The kits & reagents segment held the largest revenue share in 2023. Isolation of extracellular vesicles can be difficult, non-specific, and a tedious process. Hence, key players are launching innovative kits and reagents to broaden the applications of exosomes, which is fueling the segment growth
  • By workflow, the downstream analysis segment accounted for the largest share in 2023. Major players are offering various technologically advanced products for increasing the utility of downstream analyses, which can positively affect the segment growth
  • The cancer application segment dominated the market in 2023 due to the broad range of applications of exosomes in cancer diagnosis, prognosis, and treatment
  • The pharmaceutical & biotechnology companies end-use led industry in 2023 due to a rise in the R&D activities
  • North America was the dominant region in 2023 due to the presence of key players, rising government funding for the detection of new biomarkers, and high incidence of chronic conditions

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Workflow Segment
    • 1.2.3. Application Segment
    • 1.2.4. End-use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Exosomes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Technological advancements in exosomes isolation and analytical procedures
      • 3.2.1.2. Advanced applications of exosomes
      • 3.2.1.3. Growth in government and non-government initiatives for exosome research
      • 3.2.1.4. Increasing prevalence of cancer
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations pertaining to approval
      • 3.2.2.2. Challenges associated with implementation of exosome-based therapies
  • 3.3. Exosomes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Exosomes Market: Product & Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Exosomes Market Product & Service Movement Analysis
  • 4.3. Global Exosomes Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Kits & reagents
    • 4.4.1. Kits & reagents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Exosomes Market: Workflow Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Exosomes Market Workflow Movement Analysis
  • 5.3. Global Exosomes Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 5.4. Isolation Methods
    • 5.4.1. Isolation methods market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Ultracentrifugation
      • 5.4.2.1. Ultracentrifugation market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Immunocapture on beads
      • 5.4.3.1. Immunocapture on beads market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Precipitation
      • 5.4.4.1. Precipitation market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Filtration
      • 5.4.5.1. Filtration market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Others
      • 5.4.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Downstream Analysis
    • 5.5.1. Downstream analysis market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Cell surface marker analysis using flow cytometry
      • 5.5.2.1. Cell surface marker analysis using flow cytometry market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Protein Analysis using blotting & ELISA
      • 5.5.3.1. Protein Analysis using blotting & ELISA market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. RNA analysis with NGS & PCR
      • 5.5.4.1. RNA analysis with NGS & PCR market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Proteomic analysis using mass spectroscopy
      • 5.5.5.1. Proteomic analysis using mass spectroscopy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Others
      • 5.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Exosomes Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Exosomes Market Application Movement Analysis
  • 6.3. Global Exosomes Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Cancer
    • 6.4.1. Cancer market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Neurodegenerative Diseases
    • 6.5.1. Neurodegenerative diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Cardiovascular Diseases
    • 6.6.1. Cardiovascular diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Infectious Diseases
    • 6.7.1. Infectious diseases market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Exosomes Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Exosomes Market End Use Movement Analysis
  • 7.3. Global Exosomes Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Hospitals & Diagnostics Centers
    • 7.5.1. Hospitals & diagnostics centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Academic & Research Institutes
    • 7.6.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Exosomes Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Competitive scenario
      • 8.4.4.3. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.9. Denmark
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Competitive scenario
      • 8.5.9.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Competitive scenario
      • 8.6.7.3. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Singapore
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Competitive scenario
      • 8.6.8.3. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Competitive scenario
      • 8.8.5.3. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Company Profiles/Listing
    • 9.4.1. Bio-Techne
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product/Service benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Danaher
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product/Service benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Hologic Inc.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product/Service benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Fujifilm Holdings Corporation
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product/Service benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Lonza
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product/Service benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Miltenyi Biotec
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product/Service benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Qiagen
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product/Service benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Thermo Fisher Scientific, Inc.
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product/Service benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Abcam Plc
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product/Service benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. RoosterBio, Inc.
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product/Service benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 5 Global exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Global exosomes market, by region, 2018 - 2030 (USD Million)
  • Table 8 North America exosomes market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 10 North America exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 11 North America exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 12 North America exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 U.S. exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 14 U.S. exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 15 U.S. exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 16 U.S. exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Canada exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 18 Canada exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 19 Canada exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 20 Canada exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Mexico exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 22 Mexico exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 23 Mexico exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 24 Mexico exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Europe exosomes market, by country, 2018 - 2030 (USD Million)
  • Table 26 Europe exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 27 Europe exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 28 Europe exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 29 Europe exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 UK exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 31 UK exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 32 UK exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 33 UK exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Germany exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 35 Germany exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 36 Germany exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 37 Germany exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 France exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 39 France exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 40 France exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 41 France exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Italy exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 43 Italy exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 44 Italy exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 45 Italy exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Spain exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 47 Spain exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 48 Spain exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 49 Spain exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Denmark exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 51 Denmark exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 52 Denmark exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 53 Denmark exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Sweden exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 55 Sweden exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 56 Sweden exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 57 Sweden exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 Norway exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 59 Norway exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 60 Norway exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 61 Norway exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific exosomes market, by country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Japan exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 68 Japan exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 69 Japan exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 70 Japan exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 China exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 72 China exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 73 China exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 74 China exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 India exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 76 India exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 77 India exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 78 India exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Australia exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 80 Australia exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 81 Australia exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 82 Australia exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 Thailand exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 84 Thailand exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 85 Thailand exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 86 Thailand exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 South Korea exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 88 South Korea exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 89 South Korea exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 90 South Korea exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 Singapore exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 92 Singapore exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 93 Singapore exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 94 Singapore exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Latin America exosomes market, by country, 2018 - 2030 (USD Million)
  • Table 96 Latin America exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 97 Latin America exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 98 Latin America exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 99 Latin America exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 Brazil exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 101 Brazil exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 102 Brazil exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 103 Brazil exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 104 Argentina exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 105 Argentina exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 106 Argentina exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 107 Argentina exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa exosomes market, by country, 2018 - 2030 (USD Million)
  • Table 109 Middle East & Africa exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 110 Middle East & Africa exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 111 Middle East & Africa exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 112 Middle East & Africa exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 113 South Africa exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 114 South Africa exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 115 South Africa exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 116 South Africa exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 117 Saudi Arabia exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 118 Saudi Arabia exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 119 Saudi Arabia exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 120 Saudi Arabia exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 121 UAE exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 122 UAE exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 123 UAE exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 124 UAE exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 125 Kuwait exosomes market, by product & service, 2018 - 2030 (USD Million)
  • Table 126 Kuwait exosomes market, by workflow, 2018 - 2030 (USD Million)
  • Table 127 Kuwait exosomes market, by application, 2018 - 2030 (USD Million)
  • Table 128 Kuwait exosomes market, by end-use, 2018 - 2030 (USD Million)
  • Table 129 Participant's overview
  • Table 130 Financial performance
  • Table 131 Key companies undergoing acquisitions
  • Table 132 Key companies undergoing collaborations & partnerships
  • Table 133 Key companies launching new products/services
  • Table 134 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market outlook
  • Fig. 9 Market segment snapshot
  • Fig. 10 Competitive landscape snapshot
  • Fig. 11 Market driver impact
  • Fig. 12 Market restraint impact
  • Fig. 13 Porter's analysis
  • Fig. 14 PESTEL analysis
  • Fig. 15 Exosome market: Product & service outlook and key takeaways
  • Fig. 16 Exosome market: Product & service movement analysis
  • Fig. 17 Global kits & reagents market, 2018 - 2030 (USD Million)
  • Fig. 18 Global instruments market, 2018 - 2030 (USD Million)
  • Fig. 19 Global services market, 2018 - 2030 (USD Million)
  • Fig. 20 Exosome market: Workflow outlook and key takeaways
  • Fig. 21 Exosome market: Workflow movement analysis
  • Fig. 22 Global isolation methods market, 2018 - 2030 (USD Million)
  • Fig. 23 Global ultracentrifugation market, 2018 - 2030 (USD Million)
  • Fig. 24 Global immunocapture on beads market, 2018 - 2030 (USD Million)
  • Fig. 25 Global precipitation market, 2018 - 2030 (USD Million)
  • Fig. 26 Global filtration market, 2018 - 2030 (USD Million)
  • Fig. 27 Global other isolation methods market, 2018 - 2030 (USD Million)
  • Fig. 28 Global downstream analysis market, 2018 - 2030 (USD Million)
  • Fig. 29 Global cell surface marker analysis using flow cytometry market, 2018 - 2030 (USD Million)
  • Fig. 30 Global protein analysis using blotting & ELISA market, 2018 - 2030 (USD Million)
  • Fig. 31 Global RNA analysis with NGS & PCR market, 2018 - 2030 (USD Million)
  • Fig. 32 Global proteomic analysis using mass spectroscopy market, 2018 - 2030 (USD Million)
  • Fig. 33 Global other downstream analysis market, 2018 - 2030 (USD Million)
  • Fig. 34 Exosome market: Application outlook and key takeaways
  • Fig. 35 Exosome market: Application movement analysis
  • Fig. 36 Global cancer market, 2018 - 2030 (USD Million)
  • Fig. 37 Global neurodegenerative diseases market, 2018 - 2030 (USD Million)
  • Fig. 38 Global cardiovascular diseases market, 2018 - 2030 (USD Million)
  • Fig. 39 Global infectious diseases market, 2018 - 2030 (USD Million)
  • Fig. 40 Global other applications market, 2018 - 2030 (USD Million)
  • Fig. 41 Exosome market: End-use outlook and key takeaways
  • Fig. 42 Exosome market: End-use movement analysis
  • Fig. 43 Global pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 44 Global hospitals & diagnostics centers market, 2018 - 2030 (USD Million)
  • Fig. 45 Global academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 46 Exosome market: Regional outlook and key takeaways
  • Fig. 47 North America exosome market, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. key country dynamics
  • Fig. 49 U.S. exosome market, 2018 - 2030 (USD Million)
  • Fig. 50 Canada key country dynamics
  • Fig. 51 Canada exosome market, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico key country dynamics
  • Fig. 53 Mexico exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Europe exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 UK key country dynamics
  • Fig. 56 UK exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Germany key country dynamics
  • Fig. 58 Germany exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 France key country dynamics
  • Fig. 60 France exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Italy key country dynamics
  • Fig. 62 Italy exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Spain key country dynamics
  • Fig. 64 Spain exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Denmark key country dynamics
  • Fig. 66 Denmark exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Sweden key country dynamics
  • Fig. 68 Sweden exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Norway key country dynamics
  • Fig. 70 Norway exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Asia-Pacific exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Japan key country dynamics
  • Fig. 73 Japan exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 China key country dynamics
  • Fig. 75 China exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 India key country dynamics
  • Fig. 77 India exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Australia key country dynamics
  • Fig. 79 Australia exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Thailand key country dynamics
  • Fig. 81 Thailand exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 South Korea key country dynamics
  • Fig. 83 South Korea exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Singapore key country dynamics
  • Fig. 85 Singapore exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Latin America exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Brazil key country dynamics
  • Fig. 88 Brazil exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Argentina key country dynamics
  • Fig. 90 Argentina exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 MEA exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 South Africa key country dynamics
  • Fig. 93 South Africa exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Saudi Arabia key country dynamics
  • Fig. 95 Saudi Arabia exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 UAE key country dynamics
  • Fig. 97 UAE exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Kuwait key country dynamics
  • Fig. 99 Kuwait exosome market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Market participant categorization
  • Fig. 101 Exosomes market position analysis, 2023
  • Fig. 102 Strategy framework